FDA Investigator Nancy A Bellamy
Nancy A Bellamy has conducted inspections on 134 sites in 17 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
134
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Argentina,
United States of America,
Italy,
United Kingdom of Great Britain and Northern Ireland,
India,
South Africa,
Canada,
Zambia,
Czechia,
Belgium,
Hong Kong,
China,
Egypt,
Jordan,
Chile,
France,
Brazil
FDA Investigators that have inspected at least one site in common with Nancy A Bellamy:
Ademola O Daramola,
Alanna L Mussawwir Bias,
Alice S Tsao,
Allen F Hall,
Amina Bashir,
Andrace L Deyampert,
Andrea A Branche,
Anthony E Keller, RPh,
Anthony R Petriella,
Art O Czabaniuk,
Azza Talaat,
Barbara A Rusin,
Barbara D Wright,
Barbara Janine Breithaupt,
Barbara M Frazier,
Bei Y He,
Bernard P Heidt,
Brian J Mundo,
Brian M Campbell,
Brian M Marosan,
Brian P Hendrickson,
Brian P Putz,
Bryan J Love,
Byron Ho, DVM,
Calvin K Cook,
Camille D Brown,
Carol Rivera Lopez, PhD,
Caroline H Le,
Catherine V Quinlan,
Cathie S Marshall,
CDR Kimberly Y Martin,
CDR Sean T Creighton,
Charisse K Green,
Charles A Snipes, PhD,
Charles M Spyr,
Chelsea J Falkowski,
Chelsea W Lamm,
Cheryl A Fuhs,
Constantin Y Philopoulos,
Corey K Reno,
Corrine M Carter,
Craig A Garmendia,
Crystal M Young Lewis,
David A Lepay, MD, PhD,
David J Gasparovich,
Dawn C Olenjack,
Deanna L Lampley,
Denise L Burosh,
Diane Cvan Leeuwen,
Dina A Tallman,
Douglas W Gronski,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dylan D Yao, MD, PhD,
Emily J Orban,
Ephrem Hunde, PhD,
Eric E Joneson,
Eric S Pittman,
Erma Zaimova,
Felicia E Armbrustmacher,
Gajendiran Mahadevan, PhD,
Gary Durbiel Goldner,
Gene R Gunn,
George C Amedro,
Gerald N Mcgirl, DDS,
Hamet M Toure, PharmD MPH,
Hasan A Irier, PhD,
Herbert M Corbello,
Jacqueline Mdiaz Albertini,
James M Kewley,
Jeanne J Thai,
Jeffrey D Meng,
Jennifer A Kemp,
Jennifer C Adams,
Jennifer L Sheehan,
Joanne M Schlossin,
Joel D Martinez,
John A Kadavil, PhD,
José E Meléndez,
Joseph D Cooper,
Joseph R Haynes,
Joseph R Strelnik,
Judith A Jankowski,
Karen M Cooper,
Katherine Szestypalow,
Keith J Jasukaitis,
Kelley L Clark,
Kelli L Wilkinson,
Kellie L Thommes, RN,
Kent A Conforti,
Khairy W Malek, MD,
Khin Mang U, MD,
Kip J Hanks,
L'oreal F Walker,
Larry K Austin,
Laura E Garcia,
Laureen F Kononen,
Laureen M Geniusz,
Laverne Puckett,
Lawrence Y Lee, PhD,
Lea Cranford,
Leslie A Paul,
Li Hongpaul Yeh, PhD,
Linda R Kuchenthal,
Linda S Jozefiak,
Lisa J Joseph,
Lisa J Renick,
Lisa P Oakes,
Lori A Gioia,
Lourdes Valentin Aponte,
LT Skip A Payne,
LTJG Aaron B Otis,
Madushini Dharmasena, PhD,
Makini Cobourne Duval, PhD,
Margaret Torres Vazquez,
Marion W Nadeau,
Mark E Parmon,
Martha Sullivan Myrick,
Martin K Yau, PhD,
Matthew B Casale,
Matthew J Gretkierewicz,
Melkamu Getie Kebtie, PhD,
Michael F Skelly, PhD,
Michael P Anthony,
Michele L Forster, PhD,
Mikhail V Ovanesov, PhD,
Mra Davism,
Mra Mcculloughj,
Mra Narulaa,
Myra K Casey,
Natalie A Mickelsen, DVM,
Neali H Lucas,
Nicholas L Paulin,
Nicola M Fenty Stewart,
Nilufer M Tampal, PhD,
Niraj R Mehta, PhD,
Paige E Shelborne,
Patrick D Stone, MS,
Patsy J Domingo,
Paula M Laplant,
Peter R Lenahan,
Preston M Lee,
Rasha Bamieh,
Rebecca E Dombrowski,
Richard W Berning,
Robert D Tollefsen,
Robert G Taylor,
Robert Shibuya, MD,
Roger F Zabinski,
Rohn R Robertson,
Ronda Rloyd Jones,
Rosanna M Goodrich,
Ruben C Ayala, PharmD,
Ryan J Benedict,
Saikat I Bhuiyan,
Sam H Haidar, PhD,
Samantha J Pinizzotto, D V M,
Sargum C Sood,
Seongeun Cho (Julia), PhD,
Sherri J Jackson,
Shirley H Isbill,
Simone E Pitts,
Sripal R Mada, PhD,
Stephanie E Hubbard,
Susan D Yuscius,
Suyang Qin,
Talmane J Fisher,
Tawny L Colling,
Thomas A Peter,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tonnie L Carter,
Tracey Asinjen Wiersma,
Tracey L Harris,
Tracey L Siebesma,
Tracey L Taylor,
Twana R Chandler,
Uduak M Inokon,
Vesa Vuniqi,
Victoria A Murray,
Wayne E Seifert,
William D Tingley,
William G Nelson,
William R Brubaker,
Xiaokuang Lai, PhD,
Xikui Chen (nmi), PhD
Nancy A Bellamy's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more